BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3458293)

  • 1. Defective recloning capacity of granulocyte-macrophage colony-forming cells in chronic myeloid leukaemia.
    Olofsson T; Nilsson B
    Scand J Haematol; 1986 Feb; 36(2):168-75. PubMed ID: 3458293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    Young JW; Szabolcs P; Moore MA
    J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density distribution of chronic myeloid leukaemia and normal colony-forming cells in diffusion chambers (CFU-D) and agar (CFU-GM).
    Nilsson B; Olofsson T
    Scand J Haematol; 1985 Apr; 34(4):317-22. PubMed ID: 3858980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of responsiveness of chronic myeloid leukemia granulocyte-macrophage colony-forming cells to growth regulation in vitro following preincubation with prostaglandin E.
    Pelus LM; Gold E; Saletan S; Coleman M
    Blood; 1983 Jul; 62(1):158-65. PubMed ID: 6574794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of colony formation by CFU-GM in vitro.
    Lewis JL; Blackett NM; Gordon MY
    Br J Haematol; 1994 Oct; 88(2):440-2. PubMed ID: 7803302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS; Casale GP; Watts T
    Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease.
    Shih LY; Chiu WF; Dunn P; Liaw SJ
    Blut; 1988 Sep; 57(3):125-30. PubMed ID: 3166388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
    Bot FJ; van Eijk L; Schipper P; Backx B; Löwenberg B
    Leukemia; 1990 May; 4(5):325-8. PubMed ID: 1697008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
    Ward CS; Westwood NB; Emmerson AJ; Pearson TC
    Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation by velocity sedimentation of human haemopoietic precursors forming colonies in vivo and in vitro cultures.
    Niskanen E; Wells JR; Golde DW; Cline MJ
    Cell Tissue Kinet; 1985 Jul; 18(4):399-406. PubMed ID: 4005934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic studies on granulocyte-macrophage colony formation by mouse bone marrow cells].
    Yamaguchi Y; Misago M; Kikuchi M; Chiba S
    J UOEH; 1986 Jun; 8(2):193-9. PubMed ID: 3749651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence following splenic radiotherapy for a highly dynamic traffic of CFU-GM between the spleen and other organs in chronic granulocytic leukaemia.
    Morris TC; Vincent PC; Gunz FW; Sutherland R; Zbroja R; Irvine AE; Forrest PR
    Leuk Res; 1987; 11(2):109-17. PubMed ID: 3469481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.